Imran Ahmada,
Vinay Pathaka,
Prema G. Vasudevb,
Hardesh K. Mauryaa and
Atul Gupta*a
aMedicinal Chemistry Department, Central Institute of Medicinal and Aromatic Plants, PO. CIMAP, Kukrail Road, Lucknow-226015, India. E-mail: atisky2001@yahoo.co.in; Tel: +91 5222718556
bMetabolic & Structural Biology Department, CSIR-Central Institute of Medicinal and Aromatic Plants, P.O. CIMAP, Kukrail Road, Lucknow-226015, India
First published on 13th May 2014
Borontribromide (BBr3) is a well-known demethylating agent. The current investigation was focused on a new application of borontribromide as a C–C bond forming agent in cyclic ketones. In this study, borontribromide mediated C–C bond formation reactions of tetralones, chromenone, thiochromenone and indanones were explored. A methoxy group containing ketones showed selective C–C bond formation reaction instead of demethylation of the methoxy group. MM2 steric energy calculations for the final products showed that the reaction favored the formation of exo- or endo-cyclic double bond containing products, depending upon their low MM2 steric energy in a specific frame structure, as observed in X-ray crystallography. A comprehensive crystallographic and pi-stacking analysis of product 10a demonstrated the formation of 10a as an enantiomeric mixture, and its centre of inversion was stabilized by a set of three unique pi–pi interactions.
The synthesis of 3-(4-hydroxyphenyl)tetralone started with a Friedel–Craft acylation reaction on anisole (1) using phenylacetic acid (2) in polyphosphoric acid (PPA), which yielded 4-methoxy deoxybenzoin (3) in good yield.6 Subsequently, a Reformatsky reaction on compound 3 with ethyl bromoacetate and zinc dust in dry diethyl ether and benzene mixture yielded compounds 4 and 5 (Scheme 1).7
Both compounds 4 and 5 were subjected to catalytic hydrogenation using 10% palladium on charcoal (Pd–C) and hydrogen gas at room temperature, which gave a common reaction product 6. Note that due to the approximately same Rf of 5 and 6, the reaction was monitored by 1H NMR.8 Alkaline hydrolysis of compound 6 yielded a corresponding acid derivative (7) in quantitative yield. Thereafter, compound 7 upon intramolecular cyclization in the presence of PPA yielded 3-(4-methoxyphenyl)tetralone (8a) in 80% yield (Scheme 1).
In our initial attempts to transform 3-(4-methoxyphenyl)tetralone (8a) into the corresponding hydroxy derivative (9), we used pyridinium hydrochloride as a demethylating agent over a temperature range of 160–170 °C, which gave the desired compound (9) in 85% yield (Table 1). Due to the high temperature of this reaction, we explored other demethylating agents that were reported in the literature, which could be used under normal reaction conditions. In our attempts, we used borontribromide (BBr3), which is another versatile demethylating agent used with a variety of substrates at low temperature.
| S.no. | Catalyst/solvent | Temp. (°C) | Time (min) | Yield of 9 (%) | Yield of 10a (%) |
|---|---|---|---|---|---|
| a No solvent.b DCM under N2.c DCM without N2.d Product is not formed.e 3 equivalent.f 2 equivalent.g 1 equivalent.h No reaction. | |||||
| 1 | C5H5N·HCla | 160–170 | 60 | 85 | d |
| 2 | BBr3b,e | −78 | 70 | d | 81 |
| 3 | BBr3c,e | −78 | 70 | d | 80 |
| 4 | BBr3b,e | −30 | 110 | d | 80 |
| 5 | BBr3c,e | −30 | 110 | d | 81 |
| 6 | BBr3c,e | −20 | 150 | d | 82 |
| 7 | BBr3c,e | 0 to rt | 180 | d | 82 |
| 8 | BBr3c,f | 0 to rt | 24 h | d | 53 |
| 9 | BBr3c,g | 0 to rt | 24 h | d | 29 |
| 10 | BF3OEtb | 0 to rt | 24 h | h | h |
| 11 | BF3OEtc | 0 to rt | 24 h | h | h |
| 12 | AlCl3c | 0 to rt | 24 h | h | h |
Interestingly, under these reaction conditions, the attempted demethylation using BBr3 yielded endocyclic β–γ unsaturated diastereomeric partially reduced bisnaphthalene (10a)9 instead of demethylated product 9 (Scheme 2, Table 1).
The formation of compound 10a was optimized at different temperatures with BBr3 and other Lewis acids (Table 1).
In order to optimize the reaction conditions, we attempted the reaction with different molar equivalents of BBr3 in DCM from 0 °C to room temperature. It was observed that the use of one equivalent of BBr3 yielded only 10a in 37% yield along with unreacted starting material (8a) even at an extended reaction time (24 h, Table 1). Similarly, the use of two equivalents of BBr3 gave only the compound 10a in 42% yield with recovery of 8a in 24 h. These results showed that the use of three equivalents of BBr3 was required to complete the reaction with a better yield of product 10a (Table 1). Furthermore, the suitability of the solvent for the reaction was examined using different solvents such as benzene, toluene, tetrahydrofuran (THF), dioxane and ethanol. Of these solvents, the reaction in toluene could only produce product 10a in 70% yield in 5 h, whereas the reaction could not proceed in other solvents (Table 2). Therefore, it was concluded that use of three equivalents of BBr3 in DCM from 0 °C to room temperature for the observed C–C bond forming reaction was the optimal reaction condition.
| S.no. | Catalyst | Solvent | Temp. (°C) | Time (h) | Yield of 10c (%) |
|---|---|---|---|---|---|
| a Not reported.b Using Dean–Stark trap.c 3 equivalent.d No reaction. | |||||
| 1 | (t-BuO)3Al | Toluene | Reflux | 12 | 8 (ref. 11) |
| 2 | Amberlyst-15 | Xylene | Reflux | a | 20 (ref. 12) |
| 3 | TiCl4, Et3N | Hexane, DCM, N2 | −10 | a | 70 (ref. 12) |
| 4 | TiCl4 | DCE | Reflux | a | 71 (ref. 13) |
| 5 | Amberlyst-15 | Toluene | Refluxb | 4.5 | 75 (ref. 14) |
| 6 | BBr3c | DCM | 0 to rt | 3 | 80 |
| 7 | BBr3c | THF | 0 to rt | 24 | d |
| 8 | BBr3c | 1,4-Dioxane | 0 to rt | 24 | d |
| 9 | BBr3c | Benzene | 0 to rt | 24 | d |
| 10 | BBr3c | Toluene | 0 to rt | 5 | 70 |
| 11 | BBr3c | Ethanol | 0 to rt | 24 | d |
An extensive literature survey revealed that various reagents, such as Al2O3,10 (t-BuO)3Al,11 HCl, amberlyst-29, CH3SO3H, NaOH, Triton-B, p-dimethylaminopyridine,12 TiCl4,12,13 and amberlyst-15,12,14 have been explored for C–C bond formation of 1-tetralone (8c). It was found that transition metal containing reagents were primarily applied to explore such reactions.12,13,15,16
Considering this, we were interested to explore BBr3-mediated methodology for C–C bond forming reactions in cyclic ketones at low temperature, which could be superior to other reported methods.
To establish the generality of this method, we explored various reactions of substituted tetralones and other six member ketones such as chromanone and thiochromanone as reported in Scheme 3 (Table 3).
![]() | ||
| Scheme 3 Synthesis of BBr3-mediated partially reduced bisnaphthalenes (10a–f), bischromane 10g and bisthiochromane 10h. | ||
The plausible mechanism reveals that the reaction starts by activation of the carbonyl (C
O) group of cyclic ketone 8a by BBr3, followed by formation of an intermediate (i, step I). The enolic intermediate (i) attacks the other molecule of starting precursor 8a (it was assumed that the molecule 8a was pre-activated by excess BBr3 present in the reaction) with elimination of BBr3 and subsequently eliminates H2O from intermediate ii, leading to the formation of product 10a (step II) as depicted in Scheme 4.
Furthermore, we extended the applicability of BBr3 as a C–C bond forming agent to a cyclic constrained ketone molecule with structural similarities with 10a. Thus, 3-(4-methoxyphenyl)indanone (11a) was selected, and upon reaction with BBr3 under similar reaction conditions it yielded 12a with an exocyclic α–β unsaturated ketone system instead of demethylated product 13 (Scheme 5).
![]() | ||
| Scheme 5 Synthesis of bisindene (12a) and selective demethylated product (16): (a) BBr3, dry dichloromethane, −78 °C to room temp, 5 h, (b) (CH3)2SO4, anhydrous K2CO3, dry acetone, 12 h. | ||
To elucidate the impact of steric factor at C-2 of the ketones, we further explored the reaction of BBr3 with an indanone analog (15), which was synthesized from precursor 14 and had a bulky phenyl group at the α-position (Scheme 5). Instead of a C–C bond containing product, this reaction resulted in the formation of monodemethylated product (16) selectively. Thus, the α-CH2 group was necessary for the C–C bond formation reaction and in the absence of an α-CH2 group, the reaction proceeded towards selective demethylation. Possibly, the presence of a phenyl group at the C-2 position in 15 created steric hindrance and did not pave the way for another molecule to yield bisindene. Consequently, the reaction was forced to proceed toward demethylation rather than C–C bond formation (Scheme 5). It is worthwhile to mention that demethylation of 3-(4-methoxyphenyl)indanone analogs catalyzed with BBr3 have not been reported in the literature. However, BBr3-mediated demethylation of 2-aryl substituted 3-(4-methoxyphenyl)indanone analogs have been reported in the literature.17 In general, various reagents such as HBr–AcOH, LiBr–DMF, and Py·HCl have been the preferred choice for the demethylation of indanone derivatives.18
On the basis of the results presented above (12a, Scheme 5), we have further applied our methodology to different substituted indanones (11a–g), which yielded compounds 12a–f and 17 in good yields (Schemes 6 and 7, Table 4).
![]() | ||
| Scheme 6 BBr3-catalyzed synthesis of partially reduced bisindene (12a–f) with a plausible mechanism. | ||
![]() | ||
| Scheme 7 BBr3-mediated synthesis of partially reduced endocyclic double bond containing bisindene (17) with a plausible mechanism. | ||
Compounds 12a–f were formed due to selective deprotonation from the α-CH2 of ii as shown in Scheme 6, whereas 17 was formed due to selective deprotonation from the γ-CH2 of ii as shown in Scheme 7.
Interestingly, it was observed that in the case of indanones (11a–f), the position of the double bond was exocyclic with an α–β unsaturated ketone system, whereas with the six membered cyclic ketones (8a–h), the position of the double bond was endocyclic with a β–γ unsaturated ketone system exclusively.
However, 2,3-dihydro-7-methylinden-1-one (11g) yielded endocyclic β–γ unsaturated partially reduced bisindene (17, Scheme 7, Fig. 2) as observed in the case of six membered ketones. Such an anomaly with indanone (17) could have been due to possible intramolecular steric interactions between C
O and the 7-substituted methyl group, which was less in a β–γ unsaturated arrangement than an α–β unsaturated system.
In general, the ring size of ketones had a great impact on the position of C
C bonds in products. However, in the case of compound (17), the position of the substituent had a more pronounced effect on the position of the C
C bond than the ring size of the ketone.
On the basis of the results presented above, we further explored the cross reactions between tetralones and indanones under these reaction conditions (Scheme 8). The cross reaction of tetralones 8d and 8f under these reaction conditions gave self-condensed products 10d and 10f along with inseparable cross products 18a and b in 25%, 26%, and 27% yields, respectively. Similarly, cross reaction between indanones 11c and 11b yielded self-condensed products 12c and 12b along with inseparable cross products 19a and b in 30%, 29% and 31% yields, respectively. However, cross reaction between tetralone (8d) and indanone (11c) gave only self-condensed products 10d and 12c in 37% and 33% yields, respectively, which could be presumably due to the stereochemistry of tetralone and indanone molecules and their selectivity for the formation of exo- versus endo-cyclic double bond containing products (discussed below in detail).
As observed above in the case of tetralone (8a–h) and indanone (11g), which have the same tendency to yield endocyclic double bond containing products despite their differences in stereochemistry, indanone 11g and tetralone 8d were selected for their cross reactivity. The reaction between tetralone (8d) and indanone (11g) yielded self-condensed products 10d and 17 along with crossed products 20 and 21 in 18%, 27%, 23% and 20% yields, respectively. The formation of cross products 20 and 21 could be due to the similar reactivity of tetralone 8d and indanone 11g to yield endocyclic double bond containing products.
However, the attempted C–C bond forming reaction in substituted acetophenones using BBr3 in DCM at 0 °C to room temperature did not yield any product, but rather unreacted starting material was recovered. Interestingly, a methoxy group containing acetophenone yielded only demethylated product.
O group and another from a methoxy group, was possible (Scheme 2). Due to the bulky nature of the phenyl group substituted at C-3 (either in equatorial or axial orientation), shifting of a lone pair of electrons from the O-atom of C
O would have been easier than from the O-atom of the methoxy group, resulting in the formation of intermediate i (Schemes 4, 6 and 7). This phenomenon would have forced the reaction for C–C bond formation instead of demethylation. Furthermore, in both situations (axial or equatorial), compound 8a had enough space around the C-2 atom to accommodate another 8a molecule to form partially reduced bisnaphthalenes (10a).
In the case of 12a, the pentanone ring fused with benzene had a distorted envelop shape wherein a carbonyl carbon remained on the top of the envelop and a phenyl ring attached to C-3. In this case also, compound 11a had enough space around C-2 to accommodate another molecule of 11a to yield bisindene (12a).
The selective demethylation of compound 15 by BBr3 under similar reaction conditions could be assumed due to the presence of a bulky phenyl group at C-2, which could have hampered the adjustment of another molecule of indanone at the C-2 position.
Thus, MM2 steric energy calculations of products showed that the reaction favored the formation of exo- or endo-cyclic double bond containing products, depending upon their low MM2 steric energy for a specific frame structure as obtained from X-ray crystallography.
:
1 mixture of chloroform and hexane, whereas crystals of compound 17 were obtained by slow evaporation of solvent (EtOAc–hexane; 1
:
25) at room temperature (15–18 °C).19 The molecular structures of the compound 10a, 12f and 17 with arbitrary numbering are represented in Fig. 2.
The crystal structure of 10a shows a non-planar, distorted conformation of the molecule. The crystal structure determination revealed that compound 10a had a centrosymmetric space group P
, in which the two enantiomers were related by an inversion centre.
The molecular conformation of 10a in the asymmetric unit is shown in Fig. 2a. The relative configuration of the newly generated chiral centre at C2 was found to be same as C3 (and C3′) of the product. A view of the molecule down the C1′–C2 bond clearly demonstrated the orientation of the two halves of the molecule and the relative disposition of the aromatic rings as shown in Fig. 2b. The 3-(4-methoxyphenyl)tetralone moieties were oriented at about 70° with respect to each other. Furthermore, 4-methoxyphenyl rings of 10a were oriented perpendicular to the corresponding tetralone rings. Moreover, although 10a had four aromatic rings, there were no strong intramolecular interactions involving them.
The aromatic rings in the molecule were labelled I–IV as shown in Fig. 2b. The relevant parameters for intra- and inter-molecular π–π interactions stabilizing the crystal structure are shown in Table 5.
| Type | Cg⋯Cg (Å) | C⋯C shortest (Å) | Interplanar angle (°) | Symmetry |
|---|---|---|---|---|
| a Aromatic ring labels (I–IV) as shown in Fig. 2b. Cg = centre of gravity. Intermolecular π⋯π interactions are labelled (A)–(J) for clarity in discussion. | ||||
| Intramolecular | ||||
| III–IV | 5.53 | 4.19 (C15–C16′) | 67.2 | |
| II–III | 5.77 | 3.78 (C11–C10′) | 47.9 | |
| Intermolecular | ||||
| I–II (A) | 5.31 | 3.93 (C5–C5′) | 70.0 | −x + 1, −y + 1, −z + 1 |
| I–III (B) | 4.84 | 3.66 (C7–C13) | 85.8 | −x + 1, −y + 1, −z + 1 |
| II–III (C) | 5.22 | 3.72 (C8′–C16) | 48.2 | −x + 1, −y + 1, −z + 1 |
| I–I (D) | 5.37 | 3.83 (C9–C9) | 0.2 | −x + 2, −y + 1, −z + 1 |
| I–III (E) | 5.86 | 3.82 (C8–C12) | 85.8 | −x + 2, −y + 1, −z + 1 |
| III–IV (F) | 5.53 | 3.66 (C15–C14′) | 67.2 | −x + 2, −y + 1, −z |
| II–II (G) | 4.03 | 3.32 (C7′–C7′) | 1.3 | −x + 1, −y + 2, −z + 1 |
| IV–IV (H) | 5.23 | 3.43 (C16′–C16′) | 0.0 | −x + 2, −y + 2, −z |
| IV–II (I) | 5.64 | 3.71 (C14′–C5′) | 73.6 | −x + 1, −y + 2, −z |
| IV–I (J) | 5.79 | 3.58 (C6–C13′) | 26.4 | x, y + 1, z − 1 |
The enantiomeric pair of molecules generated around the centre of inversion was stabilized by a set of three unique π–π interactions between groups I and II, I and III, and II and III (Fig. 3).
![]() | ||
| Fig. 3 Enantiomeric pair of 10a stabilized by aromatic π–π interactions (pi-stacking). Interactions are labelled as described in Table 5. | ||
The interaction I–III had an edge-to-face geometry with the ring planes inclined at an angle of 85°. However, no C–H–π interaction was present between the two rings (C–H–Cg = 2.8 Å, ∠C–H–Cg = 128°). The centrosymmetric products, thus formed, were connected through weak π–π, C–H–O and C–H–π interactions, resulting in the observed three-dimensional assemblies in crystals (Fig. 4 and 5).
![]() | ||
| Fig. 4 A view of the molecular packing of 10a down the crystallographic b-axis showing π–π (black-dotted lines) and C–H–π (blue-dotted lines) stacking. | ||
Weak π–π interactions, listed in Table 5, had centre–centre distances ranging from 4.0–5.9 Å, and the shortest C⋯C distances range from 3.32–3.93 Å. Based on the distances, it could be concluded that the interaction between tetralone rings II according to the symmetry −x + 1, −y + 2, −z + 1 (G in Table 5) was the strongest π–π interaction in the crystal. Although interactions B and E had a T-shaped geometry (edge-to-face), no C–H–π interactions were observed in any case. Interactions D, G and H had parallel displaced orientation of the aromatic panes, while the other interactions had an inclined geometry (Table 5).
There were two C–H–O hydrogen bonds, one between the carbonyl oxygen and tetralone ring II [C6′–H–O1 (−x + 1, −y + 2, −z + 1); C6′–O1 = 3.41 Å, H–O1 = 2.54 Å, ∠C6′–H–O1 = 150.7°; Fig. 5] and another between the tetralone ring I and methoxy oxygen atom O2′ [C8–H–O2′ (x, y, z + 1); C8–O2′ = 3.40 Å, H–O2′ = 2.49 Å, ∠C8–H–O2′ = 158°; Fig. 5], which further stabilized the packing of molecules along the crystallographic b and c axes. A weak C–H–π interaction was also observed between the C2–H and tetralone ring I of molecules related by the symmetry −x + 2, −y + 1, −z + 1 (C2–Cg = 3.734 Å, H–Cg = 2.84 Å, C–H–Cg = 147°; Fig. 4).
In order to gain insight into the entrapping behavior of 10a toward a host–guest relationship, we studied space filling diagrams of 8a as well as 10a (Fig. 6). The pendent methoxyphenyl groups in 10a were inclined to each other (approximately 70°), leaving little space between them for solvent molecules (or other small molecules) to be entrapped. Similarly, a close-packing of the centrosymmetrically related molecules was observed, which was stabilized by multiple aromatic interactions in 10a.
![]() | ||
| Fig. 6 Space-filling diagram (A) and centrosymmetric diagram (B) of compound 10a. Two inversion-related molecules are shown in different colours. | ||
Furthermore, compound 17 was crystallized as a racemic mixture in the centrosymmetric space group P
. The two halves of the molecule were oriented perpendicular to each other with a dihedral angle about the C2–C11 bond being 85°. The bond length of C11–C12 was 1.347 Å, and the bond angle C2–C11–C12 was 124°, which confirmed the double bond character of C11–C12.
The molecular packing in the crystal of 17 was stabilized by aromatic π–π interactions between inversion related molecules and a weak C–H–O interaction between the translated molecules along the crystallographic a-axis (Fig. 7; ESI Table S2†).
Overall, an efficient and convenient borontribromide (BBr3) mediated methodology for C–C bond formation reactions of cyclic ketones has been developed. The stereoselective C–C bond formation using borontribromide (BBr3) is under study and will be reported in the future.
:
1), which yielded pure compound 3 as a white solid in 80% yield; Rf: 0.60 (3
:
7 ethyl acetate–hexane); mp: 74–75 °C; IR (KBr, νmax/cm−1): 1680 (C
O), 160; 1H NMR (CDCl3, 300 MHz, δ ppm): 3.86 (s, 3H, OCH3), 4.45 (S, 2H, CH2), 6.94 (d, J = 9.0 Hz, 2H, ArH), 7.15 (m, 5H, ArH), 8.28 (d, J = 8.7 Hz, 2H, ArH); 13C NMR (CDCl3, 75 MHz, δ ppm): 45.68 (CH2), 55.88 (OCH3); 114.21 (2xC), 127.19, 129.05 (2xC), 129.80 (2xC), 130.05 (2xC), 131.37 (2xC), 135.39, 163.94, 196.66 (C
O); m/z: 249 [M + Na]+.
:
99.5 for 4 and 1.0
:
99 for 5) as the eluent, which yielded pure compounds 4 and 5 in 15% and 60% yields, respectively.
O); 297 [MH+].
O); 1H NMR (CDCl3, 300 MHz, δ ppm): 1.18 (t, J = 6.9 Hz and 7.2 Hz, 3H, CH3), 3.69 (s, 2H, CH2), 3.89 (s, 3H, OCH3), 4.12 (q, 2H, CH2), 6.92 (d, J = 9.0 Hz, 2H, ArH), 6.97 (s, 1H, CH), 7.26 (m, 1H, ArH), 7.37 (m, 4H, ArH), 7.46 (dd, J = 2.1 Hz and 1.5 Hz 2H, ArH); 13C NMR (CDCl3, 75 MHz, δ ppm): 14.52 (CH3), 37.07 (CH2), 55.71 (OCH3), 61.18 (CH2), 114.25 (2xC), 127.41, 127.76 (2xC), 128.80 (2xC), 129.16 (2xC), 130.13, 134.48, 134.53, 138.06, 159.62, 172.06 (C
O); 297 [MH+].
:
3). The mixture was flushed with nitrogen gas. Palladium charcoal (Pd/C, 5 wt%) (4.0 g) was added, and hydrogen gas was passed for 24 h. The progress of the reaction was monitored by TLC (10% ethyl acetate–hexane) and 1H NMR. After completion of the reaction, the solvent was evaporated and crude material was worked up using ethyl acetate and water. The organic layer was then separated, dried over anhydrous sodium sulphate (Na2SO4) and concentrated. The crude material was purified by column chromatography using silica gel (100–200 mesh size) and ethyl acetate–hexane (0.5
:
99.5) as the eluent, which yielded pure compound 6 as oil in 96% yield; Rf: 0.27 (10% ethyl acetate–hexane); IR (KBr, νmax/cm−1): 1733 (C
O); 1H NMR (acetone-D6, 300 MHz, δ ppm): 1.08 (t, J = 7.2 Hz and 7.2 Hz, 3H, CH3), 2.59 (m, 2H, CH2), 2.93 (m, 2H, CH2), 3.36 (m, 1H, CH), 3.72 (s, 3H, OCH3), 3.93 (q, 2H, CH2), 6.80 (d, J = 8.7 Hz, 2H, ArH), 7.16 (m, 7H, ArH); 13C NMR (acetone-D6, 75 MHz, δ ppm): 13.98, 40.71 (CH2), 42.97 (CH2), 43.75, 54.88, 59.96 (CH2), 113.88, 126.31, 128.45 (2xC), 129.55, 135.95, 140.54, 158.72 (phenolic), 171.88 (C
O); mass: 283 [M − CH3]+, 337 [M + K]+.
O), 1609, 1513, 1437, 1242, 1033, 961, 822, 700; 1H NMR (acetone-D6, 300 MHz, δ ppm): 2.59 (m, 2H, CH2), 2.93 (m, 2H, CH2), 3.37 (m, 1H, CH), 3.73 (s, 3H, OCH3), 6.80 (d, J = 8.7 Hz, 2H, ArH), 7.16 (m, 7H, ArH); 13C NMR (acetone-D6, 75 MHz, δ ppm): 40.22 (CH2), 42.99 (CH2), 43.59, 54.86, 113.88, 126.25, 128.41, 128.96 (2xC), 129.54 (2xC), 136.14, 140.62, 158.69 (phenolic), 172.95 (C
O); mass: 269 [M − H]+.
:
96), which yielded pure compound 8 as an off-white solid in 80% yield; Rf: 0.86 (30% ethyl acetate–hexane); mp: 88–89 °C; IR (KBr, νmax/cm−1): 1679 (C
O); 1H NMR (acetone-D6, 300 MHz, δ ppm): 2.81 (m, 2H, CH2), 3.20 (m, 2H, CH2), 3.38 (m, 1H, CH), 3.77 (s, 3H, OCH3), 6.91 (d, J = 8.7 Hz, 2H, ArH), 7.41 (m, 4H, ArH), 7.55 (m, 1H, CH), 7.97 (d, J = 9.0 Hz, 1H, ArH); 13C NMR (acetone-D6, 75 MHz, δ ppm): 37.85 (CH2), 40.63 (2C), 46.30 (CH2), 55.02, 114.33 (2xC), 126.85, 127.01, 128.17, 129.43, 132.62, 133.87, 136.49, 144.19, 159.01 (phenolic), 196.99 (C
O); mass: 253.3 [MH+], 275.2 [M + Na]+, 291.1 [M + K]+.
O); 1H NMR (CDCl3, 300 MHz, δ ppm): 2.37 (t, J = 14.4 Hz, 1H, CH of CH2), 2.68 (dd, J = 5.4 Hz & 14.7 Hz, 1H, CH of CH2), 3.24 (dd, J = 16.2 Hz & 13.2 Hz, 1H, CH of CH2), 3.43 (t, J = 12.3 Hz, 1H, CH of CH2), 3.64 (m, 2H, CH2), 3.78 (m, 7H, CH and 2xOCH3), 5.604 (s, 1H, CH), 6.80 (m, 6H, ArH), 6.98 (m, 3H, ArH), 7.05 (m, 3H, ArH), 7.31 (d, J = 7.2 Hz, 1H, ArH), 7.67 (m, 1H, ArH), 7.79 (m, 1H, CH), 8.21 (d, J = 7.5 Hz, 1H, ArH); 13C NMR (CDCl3, 75 MHz, δ ppm): 37.31 (CH2), 38.21 (CH2), 40.05 (CH), 44.34 (CH), 55.17 (OCH3), 55.26 (OCH3), 62.51 (CH), 113.63 (2xAr–H), 113.74 (2xAr–H), 124.49 (Ar–H), 126.12 (Ar–H), 126.78 (Ar–H), 127.09 (Ar–H), 127.63 (Ar–H), 128.00 (Ar–H), 128.37 (2xAr–H), 128.46 (2xAr–H), 128.77 (Ar–H), 132.09, 132.23, 133.89 (2C), 134.83 (
CH), 136.24 (Ar–H), 137.38, 142.98, 158.01 (phenolic), 158.42 (phenolic), 197.47 (C
O); MS: 487 [MH+], 509 [M + Na]+, 525 [M + K]+; HRMS (ESI): calcd 487.2273 [MH+]; found: 487.2267; anal. calcd (C34H30O3): C, 83.92; H, 6.21; found: C, 83.80; H, 6.18%.
O); 1H NMR (CDCl3, 300 MHz, δ ppm): 2.23 (m, 1H, CH of CH2), 2.62 (dd, J = 6.3 Hz and 15.0 Hz, 1H, CH of CH2), 3.15 (dd, J = 3.6 Hz and 15.9 Hz, 1H, CH of CH2), 3.39 (t, J = 12.0 Hz, 1H, CH of CH2), 3.63 (s, 3H, OCH3), 3.71 (m, 2H, 2xCH), 3.79 (dd, J = 3.6 Hz and 11.7 Hz, 1H, CH), 3.83 (s, 3H, OCH3), 5.64 (s, 1H,
CH), 6.63 (s, 1H, ArH), 6.63 (d, J = 2.1 Hz, 1H, ArH), 6.83 (d, J = 6.6 Hz, 2H, ArH), 6.90 (d, J = 11.7 Hz, 1H, ArH), 6.97 (d, J = 20.7 Hz, 2H, ArH), 7.05–7.28 (m, 8H, Ar–H), 7.68 (s, 1H, ArH); 13C NMR (CDCl3, 75 MHz, δ ppm): 36.69 (CH2), 37.65 (CH2), 41.82 (CH), 45.88 (CH), 55.52 (OCH3), 56.00 (OCH3), 62.50 (CH), 110.39 (Ar–H), 111.62 (Ar–H), 111.96 (Ar–H), 122.62 (Ar–H), 126.62 (Ar–H), 127.17 (Ar–H), 127.93 (2xAr–H), 128.01 (2xAr–H), 128.61 (Ar–H), 128.67 (2xAr–H), 128.87 (2xAr–H), 130.42 (Ar–H), 133.44, 133.81, 134.58, 135.00, 135.90, 136.94 (Ar–H), 143.16, 145.73, 158.31 (phenolic), 159.20 (phenolic), 197.70 (C
O); MS: 487.4 [MH+]; HRMS (ESI): calcd 487.2273 [MH+]; found: 487.2256; anal. calcd (C34H30O3): C, 83.92; H, 6.21; found: C, 83.82; H, 6.17%.
O); 1H NMR (CDCl3, 300 MHz, δ ppm): 2.32 (m, 3H, CH and CH2), 2.41 (m, 1H, CH of CH2), 2.75 (t, J = 8.1 Hz, 2H, CH2), 3.01 (m, 2H, CH2), 3.86 (t, J = 3.9 Hz 1H, CH), 5.80 (t, J = 4.5 Hz, 1H,
CH), 7.08–7.15 (m, 4H, ArH), 7.26 (m, 1H, ArH), 7.34 (m, 1H, ArH), 7.50 (m, 1H, ArH), 8.10 (m, 1H, ArH); 13C NMR (CDCl3, 75 MHz, δ ppm): 23.59 (CH2), 28.54 (CH2), 28.68 (CH2), 29.18 (CH2), 51.21 (CH), 123.54 (
CH), 126.70 (Ar–H), 127.15 (Ar–H), 127.20 (Ar–H), 127.55 (Ar–H), 128.04 (Ar–H), 128.23 (Ar–H), 129.19 (Ar–H), 133.46, 133.82 (CH), 134.25, 135.72, 137.38, 144.48, 191.41 (C
O); MS: 297 [M + Na]+; anal. calcd (C20H18O): C, 87.56; H, 6.61; found: C, 87.48; H, 6.58%.
O); 1H NMR (CDCl3, 300 MHz, δ ppm): 2.11–2.38 (m, 4H, CH2 and 2xCH), 2.58–2.74 (m, 2H, CH2), 2.84–3.04 (m, 2H, 2xCH), 3.78 (s 3H, OCH3), 3.85 (m, 1H, CH), 3.92 (s, 3H, OCH3), 5.64 (t, J = 7.2 Hz, 1H, CH), 6.66–6.71 (m, 3H, ArH), 6.85 (dd, J = 2.4 Hz and 8.7 Hz, 1H, ArH), 7.01 (d, J = 8.1 Hz, 1H, ArH), 8.07 (d, J = 8.7 Hz, 1H, ArH); 13C NMR (CDCl3, 75 MHz, δ ppm): 23.54 (CH2), 28.68 (CH2), 29.11 (CH2), 29.21 (CH2), 50.97 (CH), 55.62 (OCH3), 55.83 (OCH3), 111.29 (
CH), 112.94 (Ar–H), 113.63 (Ar–H), 114.37 (Ar–H), 124.77 (Ar–H), 124.99 (Ar–H), 127.21, 127.38, 130.48 (Ar–H), 135.37, 139.28, 147.00, 158.73 (phenolic), 164.01 (phenolic), 198.30 (C
O); MS: 335 [MH+]; anal. calcd (C22H22O3): C, 79.02; H, 6.63; found: C, 78.91; H, 6.57%.
O); 1H NMR (CDCl3, 300 MHz, δ ppm): 2.23–2.27 (m, 3H, CH2), 2.32–2.43 (m, 1H, CH2), 2.60–2.71 (m, 2H, CH2), 2.83–3.022 (m, 2H, CH2), 3.73 (m, 7H, CH2 and 2xOCH3), 5.79 (t, J = 4.5 Hz, 1H,
CH), 6.69 (t, 2H, J = 2.1 Hz, ArH), 7.07 (dd, J = 3.0 Hz and 8.4 Hz, 2H, ArH), 7.16 (d, J = 8.1 Hz, 1H, ArH), 7.58 (d, J = 2.4 Hz, 1H, ArH); 13C NMR (CDCl3, 75 MHz, δ ppm): 23.95 (CH2), 27.54 (CH2), 27.73 (CH2), 29.37 (CH2), 50.84 (CH), 55.71 (OCH3), 55.91 (OCH3), 109.90 (Ar–H), 110.58 (Ar–H), 111.42 (
CH), 122.21 (Ar–H), 128.11 (Ar–H), 128.72 (Ar–H), 129.57, 130.40 (Ar–H), 134.23, 135.36, 135.64, 137.09, 158.64 (phenolic), 158.84 (phenolic), 199.38 (C
O); MS: 335.4 [MH+]; anal. calcd (C22H22O3): C, 79.02; H, 6.63; found: C, 78.93; H, 6.58%.
O); 1H NMR (CDCl3, 300 MHz, δ ppm): 1.55 (s, 1H, CH), 2.18–2.38 (m, 4H, CH2), 2.66 (t, J = 7.8 Hz, 2H, CH2), 2.78–3.011 (m, 2H, CH2), 3.75 (s, 3H, OCH3), 3.80 (s, 3H, OCH3), 3.92 and 3.94 (s, 6H, 2xOCH3), 5.64 (t, J = 4.2 Hz, 1H,
CH), 6.68, 6.703 & 6.736 (s, 3H, ArH), 7.59 (s, 1H, ArH); 13C NMR (CDCl3, 75 MHz, δ ppm): 23.72 (CH2), 27.73 (CH2), 28.37 (CH2), 29.34 (CH2), 50.42 (CH), 56.37 (OCH3), 56.43 (OCH3), 56.46 (OCH3), 56.57 (OCH3), 108.52 (Ar–H), 109.25 (Ar–H), 110.62 (Ar–H), 112.08 (Ar–H), 125.22 (
CH), 126.73, 127.05, 130.39, 135.38, 139.38, 147.54 (phenolic), 148.16 (phenolic), 148.51 (phenolic), 154.05 (phenolic), 198.42 (C
O); MS: 395 [MH+]; anal. calcd (C24H26O5): C, 73.08; H, 6.64; found: C, 72.98; H, 6.59%.
O); 1H NMR (acetone-d6, 300 MHz, δ ppm): 1.06 (s, 3H, CH3), 1.21 (s, 3H, CH3), 1.30 (s, 3H, CH3), 1.35 (s, 3H, CH3), 3.64 (s, 3H, OCH3), 3.68 (s, 1H, CH), 3.76 (s, 3H, OCH3), 5.27 (s, 1H,
CH), 6.22 (d, 1H, J = 1.5 Hz, ArH), 6.37 (s, 2H, ArH), 6.49 (d, 1H, J = 1.2 Hz, ArH), 7.31 (d, 1H, J = 8.4 Hz, ArH), 7.61 (d, 1H, J = 8.7 Hz, ArH); 13C NMR (acetone-d6, 75 MHz, δ ppm): 24.37 (CH3), 26.36 (CH3), 26.84 (CH3), 27.23 (CH3), 55.10 (OCH3), 55.65 (OCH3), 75.74, 81.86, 101.64 (Ar–H), 102.72 (Ar–H), 106.75 (Ar–H), 109.80 (Ar–H), 114.20, 116.16, 125.16 (Ar–H), 127.92, 128.89 (
CH), 155.03, 161.29 (phenolic), 161.63 (phenolic), 166.74, 190.04 (C
O); MS: 395 [MH+]; anal. calcd (C24H26O5): C, 73.08; H, 6.64; found: C, 72.98; H, 6.59%.
O); 1H NMR (CDCl3, 300 MHz, δ ppm): 3.150–3.29 (m, 2H, CH2), 3.36–3.54 (m, 2H, CH2), 4.09 (dd, J = 3.6 and 11.4 Hz, 1H, CH), 5.88 (t, J = 5.4 Hz, 1H,
CH), 7.096–7.30 (m, 3H, ArH), 7.33–7.36 (m, 1H, ArH), 7.38–7.43 (m, 3H, ArH), 8.18 (dd, J = 1.5 and 8.1 Hz, 1H, Ar–H); 13C NMR (CDCl3, 75 MHz, δ ppm): 25.26 (CH2), 32.02 (CH2), 52.48 (CH), 122.55 (
CH), 125.54 (2xAr–H), 126.14 (Ar–H), 128.02 (Ar–H), 128.10 (Ar–H), 128.58 (Ar–H), 130.28 (Ar–H), 131.71, 133.03, 133.77 (Ar–H), 134.62, 136.59, 142.39, 194.87 (C
O); MS: 311.2 [MH+]; HRMS (ESI): calcd 311.0564 [MH+]; found: 311.0546; anal. calcd (C18H14OS2): C, 69.64; H, 4.55; found: C, 69.54; H, 4.51%.
:
96) as the eluent, which yielded pure compound 12.
O); 1H NMR (CDCl3, 300 MHz, δ ppm): 0.88 (t, 1H, J = 6.6 Hz, CH of CH2), 1.25 (t, 1H, J = 6.9 Hz, CH of CH2), 3.74 (s, 3H, OMe), 3.78 (s, 3H, OMe), 4.46 (t, 1H, J = 4.2 Hz, CH), 5.36 (s, 1H, CH), 6.80–6.84 (m, 3H, ArH), 6.98–7.15 (m, 4H, ArH), 7.23–7.39 (m, 7H, ArH), 7.42–7.57 (m, 1H, ArH), 7.81 (d, 1H, J = 7.8, ArH); 13C NMR (CDCl3, 75 MHz, δ ppm): 43.64 (CH2), 48.89 (CH), 49.03 (CH), 55.58 (OCH3), 55.67 (OCH3), 114.41 (2xAr–H), 114.70 (Ar–H), 114.92 (Ar–H), 124.05 (Ar–H), 125.10, 125.91 (Ar–H), 126.30 (Ar–H), 127.38 (Ar–H), 127.62 (Ar–H), 127.88 (Ar–H), 128.66 (2xAr–H), 129.07 (2xAr–H), 129.96, 131.12 (Ar–H), 134.57 (Ar–H), 135.33, 136.64, 137.69, 138.00, 139.65, 156.22, 158.82, 196.11 (C
O); MS: 457 [M − H]+; anal. calcd (C32H26O3): C, 83.82; H, 5.72; found: C, 83.70; H, 5.66%.
O); 1H NMR (CDCl3, 300 MHz, δ ppm): 3.09 (d, J = 5.1 Hz, 2H, CH2), 3.58 (d, J = 5.1 Hz, 2H, CH2), 3.96 & 4.01 (s, 14H, 4xOCH3 and CH2), 6.92 (s, 1H, ArH), 7.01 (s, 1H, ArH), 7.28 (s, 1H, ArH), 7.30 (s, 1H, ArH); 13C NMR (CDCl3, 75 MHz, δ ppm): 31.33 (CH2), 32.47 (CH2), 32.72 (CH2), 56.38 (OCH3), 56.49 (OCH3), 56.58 (OCH3), 56.66 (OCH3), 104.98 (Ar–H), 107.51 (Ar–H), 108.05 (Ar–H), 108.42 (Ar–H), 124.75, 133.43, 133.58, 143.23, 146.32, 148.98, 149.77 (phenolic), 152.24 (phenolic), 154.48 (phenolic), 154.74 (phenolic), 194.36 (C
O); MS: 367 [M + H]+; HRMS (ESI): calcd 367.1545 [MH+]; found: 367.1531; anal. calcd (C22H22O5): C, 72.12; H, 6.05; found: C, 72.01; H, 6.01%.
O); 1H NMR (CDCl3, 300 MHz, δ ppm): 3.09 (t, J = 5.7 Hz, 2H, CH2), 3.53 (t, J = 5.7 Hz, 2H, CH2), 3.86 and 3.90 (s, 8H, 2xOCH3 and CH2), 6.87–6.96 (m, 4H, ArH), 7.66 (d, J = 8.4 Hz, 1H, ArH), 7.76 (d, J = 8.4 Hz, 1H, ArH); 13C NMR (CDCl3, 75 MHz, δ ppm): 31.47 (CH2), 32.15 (CH2), 33.40 (CH2), 55.83 (OCH3), 55.94 (OCH3), 109.89 (Ar–H), 110.20 (Ar–H), 114.48 (Ar–H), 115.00 (Ar–H), 124.90, 125.50 (Ar–H), 127.33 (Ar–H), 133.75, 134.20, 151.51, 153.83, 154.43, 162.13 (phenolic), 164.63 (phenolic), 194.15 (C
O); MS: 307.3 [MH+]; anal. calcd (C20H18O3): C, 78.41; H, 5.92; found: C, 78.31; H, 5.89%.
O); 1H NMR (CDCl3, 300 MHz, δ ppm): 3.07 (t, J = 5.7 Hz, 2H, CH2), 3.57 (t, J = 5.7 Hz, 2H, CH2), 3.86–3.97 (m, 8H, 2xOCH3 and CH2), 6.97 (d, J = 8.1 Hz, 1H, ArH), 7.17 (dd, J = 3.2 and 5.7 Hz, 1H, ArH), 7.25 (s, 1H, ArH), 7.31 (s, 1H, ArH), 7.33 (s, 1H, ArH), 7.41 (d, J = 8.1 Hz, 1H, ArH); 13C NMR (CDCl3, 75 MHz, δ ppm): 30.47 (CH2), 32.53 (CH2), 32.70 (CH2), 55.94 (OCH3), 56.04 (OCH3), 105.67 (Ar–H), 111.18 (Ar–H), 117.26 (Ar–H), 123.11 (Ar–H), 126.47 (Ar–H), 127.06 (Ar–H), 127.56, 141.10, 141.53, 142.43, 144.49, 155.43, 159.23 (phenolic), 159.81 (phenolic), 195.43 (C
O); MS: 307.3 [MH+]; anal. calcd (C20H18O3): C, 78.41; H, 5.92; found: C, 78.29; H, 5.88%.
O); 1H NMR (pyridine-d5, 300 MHz, δ ppm): 2.90 (t, J = 5.7 Hz, 2H, CH2), 3.53 (t, J = 5.7 Hz, 2H, CH2), 3.83 (s, 2H, CH2), 7.54 (s, 1H, ArH), 7.58 (m, 3H, ArH), 7.74 (s, 1H, ArH), 7.78 (d, J = 8.1 Hz, 1H, ArH); MS: 405.1 [MH+]; anal. calcd (C18H12Br2O): C, 53.50; H, 2.99; found: C, 53.39; H, 2.96%.
O); 1H NMR (CDCl3, 300 MHz, δ ppm): 2.27 (s, 3H, CH3), 2.32 (s, 3H, CH3), 2.94 (t, J = 5.7 Hz, 2H, CH2), 3.40 (t, J = 5.7 Hz, 2H, CH2), 3.78 (s, 2H, CH2), 7.00–7.09 (m, 3H, ArH), 7.13 (s, 1H, ArH), 7.58 (d, J = 8.1 Hz, 1H, ArH), 7.51 (d, J = 7.8 Hz, 1H, ArH); 13C NMR (CDCl3, 75 MHz, δ ppm): 22.03 (CH3), 22.52 (CH3), 31.16 (CH2), 32.05 (CH2), 33.27 (CH2), 123.81 (Ar–H), 126.08 (Ar–H), 126.20, 126.66 (Ar–H), 126.73 (Ar–H), 128.35 (Ar–H), 128.84 (Ar–H), 137.93, 138.79, 141.33, 144.81, 149.39, 152.38, 154.89, 195.27 (C
O); MS: 275.4 [MH+]; anal. calcd (C20H18O): C, 87.56; H, 6.61; found: C, 87.43; H, 6.58%.
:
97), which yielded pure compound 15 as a white solid in 85% yield; Rf: 0.64 (10% ethyl acetate–benzene); mp: 107–108 °C; IR (KBr, νmax/cm−1): 1700 (C
O); 1H NMR (CDCl3, 300 MHz, δ ppm): 3.66 (d, J = 4.5 Hz, 1H, CH), 3.76 (bs, 6H, 2xOCH3), 4.36 (d, J = 4.2 Hz, 1H, CH), 6.61 (s, 1H, CH), 6.79 (d, J = 6.6 Hz, 2H, ArH), 6.92–6.95 (m, 3H, ArH), 7.01 (d, J = 6.6 Hz, 2H, ArH), 7.18–7.24 (m, 3H, ArH), 7.7 (d, 1H, ArH); 13C NMR (CDCl3, 75 MHz, δ ppm): 54.71 (OCH3), 55.68 (OCH3), 56.13 (CH), 65.35 (CH), 109.95 (Ar–H), 114.71 (2xAr–H), 116.80 (Ar–H), 126.13 (Ar–H), 127.45 (Ar–H), 128.69 (2xAr–H), 129.20 (2xAr–H), 129.32 (2xAr–H), 129.96, 134.98, 139.47, 159.13 (phenolic), 159.87 (phenolic), 166.30, 203.88 (C
O); MS: 345 [MH+]; anal. calcd (C23H20O3): C, 80.21; H, 5.85; found: C, 80.11; H, 5.83%.
O); 1H NMR (acetone-D6, 300 MHz, δ ppm): 3.80 (m, 4H, OCH3 and CH), 4.511 (bs, 1H, CH), 6.80 (m, 3H, ArH), 7.05 (m, 5H, ArH), 7.30 (m, 3H, ArH), 7.68 (m, 1H, ArH), 8.40 (bs, 1H, OH); 13C NMR (acetone-D6, 100 MHz, δ ppm): 54.08 (CH), 55.73 (OCH3), 65.02 (CH), 110.12, 116.01 (2xC), 116.40, 125.40, 127.12, 128.78 (3xC), 129.33 (2xC), 129.53 (2xC), 133.77, 139.91, 156.95 (phenolic), 160.09 (phenolic), 166.22, 202.39 (C
O); MS: 330 [M]+, 331 [MH+]; anal. calcd (C22H18O3): C, 79.98; H, 5.49; found: C, 79.89; H, 5.44%.
:
96) as the eluent, which yielded pure compound 17. Off-white solid; yield: 86%; Rf: 0.60 (20% ethyl acetate–hexane); mp: 123–113 °C; IR (KBr, νmax/cm−1): 1702 (C
O); 1H NMR (CDCl3, 300 MHz, δ ppm): 2.53 (s, 3H, CH3), 2.57 (s, 3H, CH3), 3.03–3.18 (m, 3H, CH2 & CH of CH2), 3.51 (p, J = 8.4 Hz, 1H, CH of CH2), 4.16 (t, J = 4.8 Hz, 1H, CH), 6.02 (s, 1H,
CH), 6.94–7.05 (m, 3H, ArH), 7.13–7.18 (m, 2H, ArH), 7.33 (d, J = 7.5 Hz, 1H, ArH); 13C NMR (CDCl3, 75 MHz, δ ppm): 18.81 (CH3), 20.65 (CH3), 35.81 (CH2), 38.01 (CH2), 49.02 (CH), 122.21 (Ar–H), 124.31 (Ar–H), 125.26 (Ar–H), 129.75 (Ar–H), 129.89 (Ar–H), 130.19, 130.91, 134.42, 134.69 (
CH), 139.83, 142.63, 144.72, 145.65, 154.09, 207.38 (C
O); MS: 275.4 [MH+]; anal. calcd (C20H18O): C, 87.56; H, 6.61; found: C, 87.40; H, 6.57%.
:
49) as the eluent, which yielded pure compounds 10d (25%) and 10f (26%) along with an inseparable mixture of 18 (18a + 18b, 27%).
O); 1H NMR (CDCl3, 300 MHz, δ ppm): 35% (18a)a + 65% (18b)b, 2.15–2.37 (m, 8H, CH2a,b), 2.63–2.83 (m, 4H, CH2a,b), 2.83–2.98 (m, 4H, CH2a,b), 3.72–3.93 (m, 20H, OMea,b and CHa,b), 5.60–5.68 (m, 2H,
CHa,b), 6.65–6.71 (m, 6H, ArHa,b), 6.85 (d, J = 11.2 Hz, 1H, ArHb), 7.03 (d, J = 10.8 Hz, 1H, ArHa), 7.59 (s, 1H, ArHa), 8.07 (d, J = 11.6 Hz, 1H, ArHb); 13C NMR (CDCl3, 75 MHz, δ ppm): 23.53, 23.73, 27.96, 28.38, 28.55, 29.16, 29.35, 30.07, 31.27, 51.00, 51.07, 55.61, 55.83, 56.37, 56.63, 108.61, 109.32, 110.61, 111.29, 112.08, 112.95, 113.66, 114.37, 124.71, 125.42, 126.98, 127.18, 130.41, 135.47, 146.98, 147.52, 148.13, 164.06, 198.27; MS: 365 [MH+].
:
49) as the eluent, which yielded pure compounds 12b (29%) and 12c (30%) along with an inseparable mixture of 19 (19a + 19b, 31%).
O); 1H NMR (CDCl3, 300 MHz, δ ppm): 30% (19a)a + 70% (19b)b, 2.99–3.06 (m, 4H, CH2a,b), 3.48–3.50 (m, 4H, CH2a,b), 3.79–3.96 (m, 22H, OMea,b & CHa,b), 6.82–6.93 (m, 6H, ArHa,b), 7.18–7.25 (m, 2H, ArHa,b), 7.61 (d, J = 11.6 Hz, 1H, ArHa), 7.72 (d, J = 11.2 Hz, 1H, ArHb); 13C NMR (CDCl3, 75 MHz, δ ppm): 30.07, 31.26, 31.45, 32.11, 32.46, 33.04, 55.82, 55.93, 56.35, 56.44, 56.54, 56.68, 104.91, 107.49, 108.45, 109.81, 110.18, 114.47, 115.13, 124.43, 125.46, 127.26, 133.54, 133.77, 134.20, 143.50, 146.34, 148.95, 151.23, 152.24, 153.44, 154.37, 154.75, 162.11, 164.62, 194.02, 207.21; MS: 337 [MH+].
:
49) as the eluent, which yielded pure compounds 10d (37%) and 12c (33%).
:
49) as the eluent, which yielded pure compounds 10d (18%), 17 (27%), 20 (23%) and 21 (20%).
O); 1H NMR (CDCl3, 400 MHz, δ ppm): 2.28–2.33 (m, 2H, CH2), 2.71 (s, 3H, CH3), 2.73–2.79 (m, 2H, CH2), 3.13 (dd, J = 17.32 and 4.50 Hz, 1H, CH2), 3.50 (q, J = 8.4 Hz, 1H, CH2), 3.78–3.79 (m, 1H, CH), 3.80 (s, 3H, OMe), 5.83 (t, J = 4.8 Hz, 1H,
CH), 6.68 (dd, J = 8.48 and 2.40 Hz, 1H, ArH), 6.74 (d, J = 2.6 Hz, 1H, ArH), 6.89 (d, J = 7.60 and 3.60 Hz, 1H, ArH), 7.18 (d, J = 7.4 Hz, 1H, ArH), 7.29 (dd, J = 7.6 and 3.6 Hz, 1H, ArH), 7.50 (t, J = 7.48 Hz, 1H, ArH); 13C NMR (CDCl3, 100 MHz, δ ppm): 18.39 (CH3), 23.18 (CH2), 28.70 (CH2), 33.90 (CH2), 51.73 (CH), 55.21 (OCH3), 110.86, 114.15, 123.92, 123.95, 125.23, 126.93, 129.39, 134.16, 134.30, 135.25, 138.83, 139.37, 154.05, 158.50, 207.40 (C
O); MS: 305 [MH+]; anal. calcd (C21H20O2): C, 82.86; H, 6.62; found: C, 82.73; H, 6.58%.
O); 1H NMR (CDCl3, 400 MHz, δ ppm): 2.40–2.47 (m, 2H, CH2), 2.56 (s, 3H, CH3), 3.00–3.06 (m, 2H, CH2), 3.35 (bs, 2H, CH2), 3.90 (s, 3H, OMe), 4.24 (t, J = 5.6 Hz, 1H, CH), 6.17 (bs, 1H,
CH), 6.76 (s, 1H, ArH), 6.91 (t, J = 2.4 Hz, 1H, ArH), 7.07 (d, 1H, ArH), 7.12 (t, J = 7.2 Hz, 1H, ArH), 7.32 (d, 1H, ArH), 8.12 (d, J = 8.8 Hz, 1H, ArH); 13C NMR (CDCl3, 100 MHz, δ ppm): 20.09 (CH3), 28.12 (CH2), 29.44 (CH2), 37.78 (CH2), 48.45 (CH), 55.47 (OCH3), 112.55, 113.31, 121.80, 124.71, 126.62, 129.43, 130.04, 130.20, 130.50, 142.55, 143.81, 144.98, 146.60, 163.65, 197.35 (C
O); MS: 305 [MH+]; anal. calcd (C21H20O2): C, 82.86; H, 6.62; found: C, 82.75; H, 6.59%.
with one molecule in the asymmetric unit. a = 9.957 (1) Å, b = 10.296 (2) Å, c = 13.293 (2) Å, α = 74.756° (4), β = 76.427°, γ = 79.167°, Z = 2, V = 1266.4 (3) Å3, Dcalc = 1.276 g cm−3. X-ray diffraction data were collected on a Bruker AXS SMART APEX CCD diffractometer using MoKα radiation (λ = 0.71073 Å). Data were acquired using the ω scan mode at room temperature (293 K). A total of 11
707 reflections were measured with 6347 unique reflections (Rint = 0.055). The structure was solved by direct methods using SHELXS and was refined against F2 with full-matrix least squares method by using SHELXL. All the nonhydrogen atoms were refined anisotropically. Moreover, all the H-atoms, except those of the methoxy group, were located from the differences in Fourier maps and were refined isotropically. Methoxy hydrogens were fixed geometrically in idealized positions and were refined using a riding atom model. The final R-factor was 0.0629 and wR = 0.1163 for 3239 observed reflections with [I > 2sigI]. The goodness-of-fit was 0.939.
with one molecule in the asymmetric unit. The unit cell dimensions were a = 7.952 (3) Å, b = 9.721 (4) Å, c = 9.932 (4) Å, α = 109.057° (7), β = 102.134° (7), γ = 92.430° (7), Z = 2, V = 704.3 (5) Å3, Dcalc = 1.294 g cm−3. Data were acquired using the ω scan mode at room temperature (293 K). The structure was solved by direct methods using SHELXS and was refined against F2 with full-matrix least squares method by using SHELXL. All nonhydrogen atoms were refined anisotropically. Moreover, all the H-atoms, except those of the methyl groups, were located from the differences in Fourier maps and were refined isotropically. Methyl hydrogens were fixed geometrically in idealized positions and were refined using a riding atom model. A total of 3617 reflections were measured with 2382 unique reflections (Rint = 0.019). The final R was 0.0574 and wR = 0.1522 for 1866 observed reflections with [I > 2
sig
I]. The goodness-of-fit was 1.075.
718 reflections were measured with 1984 unique reflections (Rint = 0.27). The final R was 0.0885 and wR = 0.1698 for 691 observed reflections with [I > 2
sig
I]. The goodness-of-fit was 0.975.
C bond and formation of product 6. Disappearance of olefinic singlets from 1H NMR spectra of 4 and 5 further confirmed the formation of compound 6.
:
1) were used for HPLC analysis of 10a;
(b) The Rf value of 10a (0.45 in 20% ethyl acetate–hexane) on TLC was much higher than that of the authentic hydroxy derivative (compound 9, Rf value 0.25 in 20% ethyl acetate–hexane) and very close to that of the starting compound (8a, Rf value 0.57). In infrared (IR) spectrum, compound 10a showed bands at 3001, 2935, and 2834 cm−1, indicating the presence of a number of CH2 and CH groups; moreover, a band at 1678 cm−1 indicated the presence of one carbonyl (C
O) functional group in the compound. Furthermore, product (10a) showed peaks at 487, 509 and 525 in its mass spectrum, which indicated that the molecular weight of 10a could be between 486 and 526. The 1H NMR of 10a had different signals for 30 protons, whereas signals in 13C NMR showed the presence of seven C-atoms in the aliphatic region (between 20–80 ppm), including two signals for two methoxy groups. In an aromatic region (between 80–200 ppm), signals were present for 27 C-atoms, including one for a carbonyl (C
O) group. From the above information, it could be deduced that compound 10a had a total of 30 protons, 34 C-atoms and 3 oxygen atoms (1 from a carbonyl group and 2 from methoxy groups). Thus, the molecular formula of 10a could be C34H30O3 with a molecular weight of 486, which was within the observed range (as in mass spectra). The double bond equivalents calculated for 10a as per this molecular formula were 20, which later accounted for 14 double bonds and 6 rings present in the molecule (Scheme 2). The spectral analysis of 1H NMR further showed the presence of a triplet and double doublet for two CH groups at 2.36 and 2.68 ppm, respectively, indicating that these signals were for H5 and H6 (germinal protons), which were attached to the C4. This was clearly observed in HSQC spectra (same C-signal for both protons). Another set of a triplet and double doublet for two CH groups at 3.43 and 3.23 ppm was for H15 and H16, respectively (Scheme 2). These protons were also attached to the same C-atom (C-4′) as shown in the HSQC spectra. The interactions between H5 and H6 as shown in the COSY spectra further revealed that these protons were in close proximity. Similarly, H15 and H16 showed interactions in COSY spectra, and therefore, these were in close proximity. Furthermore, in COSY spectra interactions between H5 and H6 with one proton that appeared at around 3.6–3.8 ppm showed its proximity to them; therefore, it could be assigned as H7. In 1H NMR, a singlet that appeared at 5.60 ppm for one proton could be assigned as a olefinic (HC
C) proton, which showed its interaction with one of the protons that appeared at around 3.6–3.8 ppm (one of the CH) in the COSY spectra. This showed its proximity with H15; therefore, it could be assigned as H14. The presence of this olefinic proton was further confirmed by 13C NMR, which showed a signal at 124.49 ppm. This information also was supported by HSQC spectra. The presence of two methoxy groups in the molecule could be explained by the presence of a multiplet at 3.78 ppm for seven protons (6 protons for two OCH3 groups and one CH) in the 1H NMR spectra and two signals at 55.17 and 55.26 ppm for methoxy groups and two signals at 158.01 and 158.42 ppm for phenolic C-atoms in 13C NMR spectra. One doublet at 8.21 ppm with a coupling constant (J) of 7.5 Hz in 1H NMR spectra showed the presence of one ortho-coupled peri-proton (H1). In the COSY spectra, this proton showed interactions with a proton appearing at 7.67 ppm, indicating its proximity to it. Therefore, it could be assigned later as H2. The DEPT spectra revealed the presence of a total of 17 CH groups and 10 quaternary C-atoms in the
aromatic region, while two CH2 groups, two methoxy groups and two CH groups were found in the aliphatic region. Thus, the structure of this compound was assigned as partially reduced bisnaphthalene (10a).Footnote |
| † Electronic supplementary information (ESI) available. CCDC 938650 (10a) and 980068 (17). For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c4ra01745e |
| This journal is © The Royal Society of Chemistry 2014 |